Preventive effect of statin pretreatment on contrast-induced acute kidney injury in patients undergoing coronary angioplasty: propensity score analysis from a multicenter registry.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  International Journal of Cardiology

• Publication date

  2014-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijcard.2013.12.017PMID 24393575
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Contrast-induced acute kidney injury.

  2018cited by this paper
• Impact of a High Loading Dose of Atorvastatin on Contrast-Induced Acute Kidney Injury

  2012cited by this paper
• Preventing radiocontrast-induced nephropathy in chronic kidney disease patients undergoing coronary angiography.

  2012cited by this paper
• Contrast-induced kidney injury: mechanisms, risk factors, and prevention.

  2012cited by this paper
• Contrast medium volume to creatinine clearance ratio: A predictor of contrast‐induced nephropathy in the first 72 hours following percutaneous coronary intervention

  2012cited by this paper
• Statins improve outcome in isolated heart valve operations: a propensity score analysis of 3,217 patients.

  2011cited by this paper
• Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] tria

  2011cited by this paper
• Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines

  2011cited by this paper
• Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions.

  2011cited by this paper
• Statins for the Prevention of Contrast-Induced Nephropathy: A Systematic Review and Meta-Analysis

  2011cited by this paper
• Mehran Contrast-Induced Nephropathy Risk Score Predicts Short- and Long-Term Clinical Outcomes in Patients With ST-Elevation–Myocardial Infarction

  2010cited by this paper
• Moderate chronic kidney disease and left ventricular hypertrophy after aortic valve replacement for aortic valve stenosis.

  2010cited by this paper
• Statins for prevention of contrast‐induced nephropathy in patients undergoing non‐emergent percutaneous coronary intervention

  2010cited by this paper
• Contrast-induced acute kidney injury.

  2010cited by this paper
• Contrast-Induced Acute Kidney Injury.

  2008cited by this paper
• Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.

  2008cited by this paper
• Pleiotropic effects of statin therapy: molecular mechanisms and clinical results.

  2008cited by this paper
• Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial--a randomized controlled study.

  2008cited by this paper
• Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease

  2007cited by this paper
• Propensity Scores in Cardiovascular Research

  2007cited by this paper
• Contrast-induced nephropathy: definition, epidemiology, and patients at risk.

  2006cited by this paper
• The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease.

  2005cited by this paper
• Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions.

  2005cited by this paper
• A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.

  2004cited by this paper
• Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia.

  2002cited by this paper
• Coronary heart disease mortality among men aged 35-44 years by prefecture in Japan in 1995-1999 compared with that among white men aged 35-44 by state in the United States in 1995-1998: vital statistics data in recent birth cohort.

  2001cited by this paper
• Coronary Heart Disease Mortality Among Men Aged 35-44 Years by Prefecture in Japan in 1995-1999 Compared With That Among White Men Aged 35-44 by State in the United States in 1995-1998

  2001cited by this paper
• Pleiotropic effects of statins

  2000cited by this paper
• Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents.

  1994cited by this paper

• Prevention of Contrast-Induced Nephropathy After Cardiovascular Catheterization and Intervention With High-Dose Strong Statin Therapy in Japan　- The PREVENT CINC-J Study.

  2022cites this paper
• Systemic immune inflammation index: is it a new marker for contrast-induced nephropathy?

  2022cites this paper
• Comparison of atorvastatin and rosuvastatin on preventing contrast-induced-nephropathy in patients undergoing primary percutaneous coronary intervention: A multi-centric randomized triple-blind clinical trial

  2020cites this paper
• Contrast-Induced Nephropathy in patients submitted to percutaneous coronary intervention: an integrative review.

  2020influential citation
• Effectiveness of contrast-associated acute kidney injury prevention methods; a systematic review and network meta-analysis

  2018cites this paper
• Risk Factors of Contrast-induced Acute Kidney Injury in Patients Undergoing Emergency Percutaneous Coronary Intervention

  2017cites this paper
• Mehran risk score for predicting contrast-induced nephropathy: Relevance to Indian population

  2017cites this paper
• Comparing common doses (double-dose vs usual-dose) of atorvastatin for preventing contrast-induced acute kidney injury and mortality after coronary angiography

  2017cites this paper
• Strategies Preventing Contrast-Induced Nephropathy After Coronary Angiography: A Comprehensive Meta-Analysis and Systematic Review of 125 Randomized Controlled Trials

  2017cites this paper
• Preventive Effect of Atorvastatin (80 mg) on Contrast-Induced Nephropathy After Angiography in High-Risk Patients: Double-Blind Randomized Clinical Trial

  2016cites this paper
• No recommendation of routine perioperative statin use for prevention of acute kidney injury in patients undergoing cardiac surgery.

  2016cites this paper
• Renoprotection by remote ischemic conditioning during elective coronary revascularization: A systematic review and meta-analysis of randomized controlled trials.

  2016cites this paper
• Statins for the prevention of contrast-induced acute kidney injury

  2016cites this paper
• The prevention of statins against AKI and mortality following cardiac surgery: A meta-analysis.

  2016cites this paper
• Xuezhikang ameliorates contrast media-induced nephropathy in rats via suppression of oxidative stress, inflammatory responses and apoptosis

  2016cites this paper
• Short-, mid-, and long-term benefits of peri-procedural high-intensity statin administration in patients undergoing percutaneous coronary intervention

  2015cites this paper
• Improvement in Renal Function and Reduction in Serum Uric Acid with Intensive Statin Therapy in Older Patients: A Post Hoc Analysis of the SAGE Trial

  2015cites this paper
• Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?

  2015influential citation
• Effect of the Mehran risk score for the prediction of clinical outcomes after percutaneous coronary intervention.

  2015cites this paper
• Implications of Kidney Disease in the Cardiac Patient.

  2014cites this paper
• of Kidney Disease in the Cardiac Patient

  2014cites this paper
• Ebola: is there a hope from treatment with cardiovascular drugs?

  2014cites this paper
• Comparison of the Efficacy of Rosuvastatin versus Atorvastatin in Preventing Contrast Induced Nephropathy in Patient with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention

  2014influential citation